Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Plc Regulatory News (HAYD)

Share Price Information for Haydale Plc (HAYD)

Share Price is delayed by 15 minutes
Get Live Data
0.2825    0.0025 (0.89%)
Bid:
0.275
Ask:
0.29
Spread: 0.015 (5.455%)
Market Cap: £21.96m
HAYD Live PriceLast checked at - London Stock Exchange

Intraday Haydale Plc Share Chart

Trading Update

7 Jun 2022 07:00

RNS Number : 9012N
Haydale Graphene Industries PLC
07 June 2022
Β 

This announcement contains inside information.

.

Β 

For immediate release

Β 7 June 2022

Β 

Haydale Graphene Industries plc

Β 

('Haydale', the 'Company', or the 'Group')

Trading Update

Haydale, (AIM: HAYD), the global advanced materials group, announces a trading update for the year ended 30 June 2022 (the "Year").

Β 

The Group anticipates announcing revenues for the Year ahead of market expectations. Revenues have been supported by the strong launch of Hi-Therm[1], with sales of functionalised boron nitride conductive fluids expected to be markedly ahead of contractual volumes, and the positive settlement that has been reached over a previously announced contractual dispute with a US group selling silicon carbide cutting tooling and wear-resistant solutions. Counteracting this have been the slower than anticipated sales of silicon carbide to East Asian customers, who have been adversely impacted by the lock downs in China. During the year, Haydale has continued to strengthen its teams across all Group sites and this investment in sales, marketing, quality and production resource will partly offset the uplift in revenue at the EBITDA level.

Β 

Haydale's HDPlasβ„’ functionalisation process is the cornerstone of the Group's graphene and other nano particle offering. The Group successfully commissioned its new HT1400 plasma reactor in April 2022, and this has increased our functionalisation capacity eight-fold and we can now functionalise up to 8 tonnes of graphene or other nano particles per month. In the final quarter of the Year, the Directors have accelerated the capital expenditure programme at the Ammanford facility to expand the Group's capacity to process Hi-Therm, to increase production and dispersion capacity for the proprietary bio-medical sensor inks and to enhance the quality control systems at the site. The increased capital investment and working capital demand has impacted cash which stood at Β£1.62 million at the end of May.

Β 

The Directors expect the commercial momentum from this Year to continue during the year ended 30 June 2023 and this reinforces confidence in the medium and long term prospects and the overall significant potential for the Group.

Β 

Keith Broadbent, Haydale CEO, said: "Our transition from a research and development focussed organisation to a commercial operation has accelerated during the 2nd half of the Year and we look forward to driving our business forward in the coming year and thereafter."

Β 

For further information:

Β 

Β 

Haydale Graphene Industries plc

Keith Broadbent, CEO

Mark Chapman, CFO

Tel: +44 (0) 1269 842 946

Β 

www.haydale.comΒ 

finnCap (Nominated Adviser & Broker)

Julian Blunt/Edward Whiley, Corporate FinanceAndrew Burdis, ECM

Β 

Tel: +44 (0) 20 7220 0500

Β 

Β 

Β 

Β 

Β 

Notes to Editors

Β 

Haydale is a global technologies group and service provider that facilitates the integration of graphene and other nanomaterials into the next generation of industrial materials and commercial technologies. With expertise in graphene, other nanomaterials and Silicon Carbide, Haydale is able to deliver improvements in electrical, thermal and mechanical properties, Haydale has been granted patents for its technologies in Europe, USA, Australia, Japan and China and operates from five sites in the UK, USA and East Asia. For more information please visit: www.haydale.com or Twitter: @haydalegraphene

Β 

Caution regarding forward looking statements

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.

Β 

A number of factors could cause actual results to differ materially from the results discussed in the forward-looking statements including risks associated with vulnerability to general economic and business conditions, competition, environmental and other regulatory changes, actions by governmental authorities, the availability of capital markets, reliance on key personnel, uninsured and underinsured losses and other factors, many of which are beyond the control of the Company. Although any forward looking statements contained in this announcement are based upon what the Directors believe to be reasonable assumptions, the Company cannot assure investors that actual results will be consistent with such forward looking statements. Accordingly, readers are cautioned not to place undue reliance on forward looking statements. Subject to any continuing obligations under applicable law or any relevant AIM Rule requirements, in providing this information the Company does not undertake any obligation to publicly update or revise any of the forward looking statements or to advise of any change in events, conditions or circumstances on which any such statement is based.

Β 

Β 


[1] In January 2022 Haydale signed an exclusive three year supply agreement with High Tech Systems Ltd to supply functionalised Boron Nitride into a thermally conductive fluid for domestic and industrial heating systems.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTFLFVRRAIRIIF
Date   Source Headline
8th Aug 20183:01 pmRNSNotification of Major Holdings
8th Aug 201811:00 amRNSPrice Monitoring Extension
7th Aug 201810:24 amRNSNOTIFICATION OF MAJOR HOLDINGS
1st Aug 20187:00 amRNSWorld's First Graphene Skinned Plane
18th Jul 20187:00 amRNSNPL & NGI launch graphene characterisation service
13th Jul 20182:05 pmRNSSecond Price Monitoring Extn
13th Jul 20182:00 pmRNSPrice Monitoring Extension
25th Jun 20187:00 amRNSPartnership with GEIC
22nd Jun 20184:20 pmRNSNotification of Major Holdings
20th Jun 20182:52 pmRNSDirector Dealing
19th Jun 20187:00 amRNSStrong Commercial Progress
18th Jun 20187:00 amRNSNotification of Major Holdings
13th Jun 20189:05 amRNSSecond Price Monitoring Extn
13th Jun 20189:00 amRNSPrice Monitoring Extension
13th Jun 20187:00 amRNSTrading Statement and Director Resignation
25th May 20187:00 amRNSHaydale Ceramics Technologies
16th Apr 20189:10 amRNSNotification of Major Holdings
1st Mar 20187:00 amRNSInterim Results
19th Feb 20187:00 amRNSSupply Agreement with Graphene Platform Corp
25th Jan 20187:00 amRNSTrading Update
18th Jan 20187:00 amRNSChange of Adviser
17th Jan 20187:00 amRNSCommercial Agreement with Talga Resources
18th Dec 20177:00 amRNSShare options and awards, LTIP and PDMR dealings
12th Dec 201711:25 amRNSResult of AGM
20th Nov 20177:00 amRNSNew Patent Application
20th Nov 20177:00 amRNSAnnual Report & Notice of AGM
1st Nov 20177:00 amRNSPDMR Dealings
31st Oct 20175:48 pmRNSNotification of Major Holdings
30th Oct 20177:00 amRNSGrant of US Patent
27th Oct 201710:45 amRNSResult of General Meeting, Issue of Equity and TVR
26th Oct 201710:06 amRNSResult of Conditional Offer
19th Oct 20171:20 pmRNSCREST Clarification
10th Oct 20174:21 pmRNSClose of Accelerated Bookbuild
10th Oct 20177:00 amRNSProposed Accelerated Bookbuild to raise £6 million
10th Oct 20177:00 amRNSFull Year Results
26th Sep 20177:00 amRNSEverpower places initial orders for Chinese market
11th Sep 20177:00 amRNSChange of Adviser
1st Sep 20177:00 amRNSNew Sales Contract
22nd Aug 20177:00 amRNSAdvanced Composites Proposed Collaboration
9th Aug 20177:00 amRNSLaunch of Taiwan operations
19th Jul 20177:00 amRNSTrading update
13th Jul 20177:00 amRNSAppointment of Chairman
29th Jun 20177:00 amRNSGrant of Options
20th Jun 20177:00 amRNSIssue of Equity and Total Voting Rights
24th May 201711:30 amRNSPDMR Dealing
15th May 20177:00 amRNSAcquisition of HTI Minority Interest
11th May 20177:00 amRNSMemorandum of Understanding with Nanospan India
9th May 20177:00 amRNSIssue of Equity and Total Voting Rights
28th Apr 20177:00 amRNSIssue of Shares
25th Apr 20177:00 amRNSPDMR Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.